FCP
CVS icon

Fidelis Capital Partners’s CVS Health CVS Stock Holding History

Fidelis Capital Partners’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.71M Buy
26,216
+412
+2% +$36.8K 0.16% 113
2026
Q1 		$1.85M Buy
25,804
+7,160
+38% +$552K 0.13% 135
2025
Q4 		$1.48M Buy
18,644
+1,913
+11% +$151K 0.11% 153
2025
Q3 		$1.26M Buy
16,731
+417
+3% +$28.6K 0.1% 164
2025
Q2 		$1.04M Buy
16,314
+2,628
+19% +$172K 0.09% 168
2025
Q1 		$894K Buy
13,686
+7,410
+118% +$443K 0.1% 169
2024
Q4 		$351K Sell
6,276
-1,010
-14% -$56.7K 0.04% 309
2024
Q3 		$414K Sell
7,286
-11,181
-61% -$652K 0.05% 264
2024
Q2 		$1.04M Sell
18,467
-4,132
-18% -$258K 0.15% 132
2024
Q1 		$1.8M Buy
22,599
+4,870
+27% +$372K 0.27% 73
2023
Q4 		$1.4M Buy
17,729
+6,357
+56% +$452K 0.31% 68
2023
Q3 		$796K Buy
11,372
+1,585
+16% +$112K 0.27% 79
2023
Q2 		$677K Buy
9,787
+775
+9% +$55.1K 0.25% 97
2023
Q1 		$637K Buy
9,012
+5,662
+169% +$475K 0.27% 94
2022
Q4 		$306K Buy
+3,350
New +$323K 0.36% 79

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelis Capital Partners's CVS Position: Q2 2026 in Review

Fidelis Capital Partners increased its CVS Health (CVS) stake by 1.6% in Q2 2026, buying an estimated $36.8K and bringing the position to 26,216 shares worth $2.71M. The position accounts for 0.16% of the portfolio, ranked #113.

Fidelis Capital Partners first reported a position in CVS in Q4 2022 and has held it in 15 quarters since. 2,074 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Fidelis Capital Partners held 26,216 shares of CVS Health worth $2.71M as of Q2 2026.
  • Fidelis Capital Partners bought 412 CVS Health shares in Q2 2026, an estimated $36.8K.
  • CVS Health made up 0.16% of Fidelis Capital Partners's portfolio in Q2 2026, its #113 holding.
  • Fidelis Capital Partners first reported a position in CVS Health in Q4 2022 and has held it in 15 quarters since.
  • 2,074 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Fidelis Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.